News

Participation in AMWC Latin America 2025

2025-10-21

본문

a9ec6120f2529e768a61b12c3121a389_1790740046_3418.png
A second year in Medellín — deepening partnerships across Latin America
Medellín, Colombia — 16–18 October 2025 — Genèse Labs returned to AMWC Latin America for a second consecutive year at Plaza Mayor Medellín, strengthening its relationships with practitioners and distribution partners across the region.

• Second consecutive participation in AMWC Latin America, following 2024
• First Latin American presentation of the expanded RG Body Filler family (RG60, RG80, RG100, RG55S)
• Presentation of the complete Proluma™ line of PDLLA and PLLA
• Existing partner relationships strengthened and new distribution discussions opened
From First Contact to Lasting Relationships
Having entered the Latin American aesthetic community with its first participation in 2024, Genèse Labs returned to Medellín a year later with an expanded portfolio. The second participation focused on turning the relationships formed in the first year into practical partnerships.
Answering Demand for Body Contouring
Latin America has particularly high demand for body treatments. At this congress, Genèse Labs presented the RG Body Filler family — now expanded from RG60® to include RG80, RG100 and the syringe-type RG55S — for the first time in the region, offering a broad choice by treatment area and volume.
A Complete Biostimulator Line
Alongside Proluma™ PDLLA, well received in the first year, the PLLA formulation for deep structural volume restoration was introduced, giving practitioners a wider range of biostimulation options. In a region where European products command high trust, CE-certified, French-developed products once again proved a strength.
“The conversations that began in our first year became partnerships in our second. Latin America is a core market in which we continue to invest.” — Genèse Labs, Company statement
About Genèse Labs
Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.


Contact
For distributor inquiries, collaborations, or product information, please contact: